麦默通旋切术用于乳腺癌病灶切除的临床价值  

The clinical value of ultrasound-guided Mammotomein for the resection of breast cancer lesions

作　　者：任宇[1] 王刚乐[1] REN Yu;WANG Gangyue(Department of Breast Surgery,Beijing Obstetrics and Gynecology Hospital,Cap-ital Medical University,Beijing 100006,China)

机构地区：[1]首都医科大学附属北京妇产医院乳腺科

出　　处：《临床外科杂志》2020年第8期764-766,共3页Journal of Clinical Surgery

摘　　要：目的探讨麦默通旋切术(Mammotome,MMT)用于乳腺癌病灶切除的临床价值。方法接受超声引导下MMT,术后病理检查确诊为乳腺癌,并接受再次开放手术病人75例,根据MMT后有无肿瘤残留分为肿瘤残留组和肿瘤无残留两组,肿瘤残留组39例,肿瘤无残留组36例。分析乳腺癌肿瘤病灶残留与临床、病理因素间的关系。结果乳腺癌MMT后肿瘤病灶残留率为52.0%。年龄、组织学类型、Ki-67表达与乳腺癌肿瘤病灶残留相关(P<0.05);年龄是乳腺癌肿瘤病灶残留的独立危险因素,P<0.05。结论乳腺癌经超声引导下MMT切除肿瘤病灶,肿瘤残留率偏高。不建议应用MMT治疗乳腺癌。Objective To investigate clinical value of ultrasound-guided Mammotome(MMT)in the treatment of breast cancer.Methods The clinical data of 75 patients with MMT and reoperation were collectedin the treatment of breast cancer.According to whether there was residual tumor after MMT,patients were divided into residual tumor group(39 cases)and non-residual group(36 cases).The relationship of residual tumorsand clinical and pathological factors between two groups was compared.Results The rate of residuallesions after MMT was 52.0%,The residual lesionswere closely related to patient age,tumor differentiation,Ki-67 expression(P<0.05);patient age was an independent risk factor for residual breast tumor(P<0.05).Conclusion There was a high rate of residual tumors after MMT in breast cancer.MMT is not recommended for breast cancer.

关 键 词：乳腺癌 麦默通 病灶残留 

分 类 号：R737.9[医药卫生—肿瘤]